Clinical Trials on Neoplasms, Neuroepithelial

Total 107351 results

Grupo Español de Investigación en Neurooncología

Completed

Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

Glioblastoma

Spain
Qingdao University

Unknown

Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma

Malignant Glioma

China
University of Zurich

Unknown

Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)

Glioblastoma

Switzerland
Medanta Institute of Clinical Research

Unknown

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

Glioblastoma
Sigma-Tau Research, Inc.
Rhode Island Hospital

Completed

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.

Malignant Glioma

United States
John Sampson
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme

Recurrent Central Nervous System Neoplasm

United States
University Hospital, Caen

Recruiting

Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs (GliomiR)

Glioma, Malignant

France
Erasmus Medical Center
Universitaire Ziekenhuizen KU Leuven; University Medical Center Groningen; Academisch... and other collaborators

Not yet recruiting

Short Term Outcomes After PRoton And photoN radiOtherapy for IDH Mutated Grade 2 and 3 Gliomas (SOPRANO)

Glioma | Radiotherapy; Complications
The Christie NHS Foundation Trust
Northern Care Alliance NHS Foundation Trust; NovoCure Ltd.; University of Manchester

Not yet recruiting

Preoperative Preradiotherapy TTFields (PORTRAIT)

Glioblastoma
Cantex Pharmaceuticals
Medpace, Inc.

Recruiting

Azeliragon in MGMT Unmethylated Glioblastoma

Glioblastoma

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype

Glioblastoma

Italy
Mayo Clinic

Recruiting

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

Glioblastoma

United States
SignPath Pharma, Inc.
Avance Clinical

Recruiting

Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas

Glioblastoma

United States
Erasmus Medical Center

Not yet recruiting

Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study. (BIOPSY)

Glioblastoma

Netherlands
Sun Yat-sen University

Recruiting

Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes

Glioma | Immune Suppression

China
Assiut University

Not yet recruiting

Single Photon Emission Computed Tomography/Computed Tomography With Pentavalent 99mTc Dimercaptosuccinic Acid in Patients With Brain Glioma; Correlation With IDH Mutation

Brain Glioma
Zhongnan Hospital

Not yet recruiting

Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma (GBM)

Glioblastoma
Epitopoietic Research Corporation

Not yet recruiting

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

Glioma, Malignant

Thailand
GT Medical Technologies, Inc.

Recruiting

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

Glioblastoma

United States
Istituto Oncologico Veneto IRCCS
Azienda Ospedaliera di Padova; Azienda Ospedaliero-Universitaria Careggi, Firenze

Recruiting

An Integrated Radio-immunological Approach (IMMUNO-IMAGING)

Glioma, Malignant

Italy
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Preoperative Radiosurgery for the Treatment of High Grade Glioma, The NeoGlioma Study

Malignant Glioma

United States
Zhongnan Hospital

Not yet recruiting

Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma (ECTG001)

Glioma | Glioblastoma

China
Centre Jean Perrin
Ministry for Health and Solidarity, France

Recruiting

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma (NANO-GBM)

Glioblastoma

France
M.D. Anderson Cancer Center

Recruiting

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

Malignant Glioma

United States
University Hospital Heidelberg

Recruiting

Glioblastoma Radiotherapy Using IMRT or Proton Beams (GRIPS)

Glioblastoma

Germany
Medical College of Wisconsin

Recruiting

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Glioblastoma

United States
Waikato Hospital
Wellington Hospital

Recruiting

Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma

Glioblastoma

New Zealand
Erasmus Medical Center
Universitaire Ziekenhuizen KU Leuven; University of California, San Francisco; Medical Center Haaglanden

Recruiting

The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections (PROGRAM)

Glioblastoma

United States, Belgium, Germany, Netherlands, Switzerland
Masonic Cancer Center, University of Minnesota
University of Minnesota

Not yet recruiting

A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma

Glioblastoma

United States
University of Michigan Rogel Cancer Center

Recruiting

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

Glioblastoma

United States
St. Olavs Hospital
Odense University Hospital; Karolinska University Hospital; Turku University... and other collaborators

Recruiting

Supramarginal Resection in Glioblastoma

Glioblastoma

Norway, Sweden, Finland, Denmark, Austria
Oslo University Hospital

Recruiting

Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy (DEN-STEM)

Glioblastoma

Norway
Medical College of Wisconsin

Recruiting

Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

Glioblastoma

United States
Johnpro Biotech, Inc.

Recruiting

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Glioblastoma

Taiwan
Patrick Wen, MD
Eli Lilly and Company; Celgene; Puma Biotechnology, Inc.; Accelerate Brain Cancer... and other collaborators

Recruiting

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Glioblastoma

United States
Universitätsmedizin Mannheim
University of California, Los Angeles; Carl Zeiss Meditec AG

Recruiting

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme (INTRAGO-II)

Glioblastoma

Korea, Republic of, Germany, Canada, Spain, United States, Brazil, China, United Kingdom
German Cancer Research Center

Active, not recruiting

AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma (AMPLIFY-NEOVAC)

Malignant Glioma

Germany
Imvax

Active, not recruiting

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Glioblastoma

United States
Hoffmann-La Roche

Active, not recruiting

A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma

Glioblastoma

United States, Spain, Australia, Canada, Netherlands, Denmark
Massachusetts General Hospital
Peregrine Pharmaceuticals; National Comprehensive Cancer Network

Completed

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Glioblastoma

United States
Inovio Pharmaceuticals

Active, not recruiting

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

Glioblastoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

Malignant Glioma

United States
Denovo Biopharma LLC

Completed

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Glioblastoma

United States, China, Canada
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Active, not recruiting

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Glioblastoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Easing Psychosocial Burden for Informal Caregivers

Glioblastoma

United States
University of Alabama at Birmingham
National Center for Advancing Translational Sciences (NCATS)

Active, not recruiting

Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom

Glioblastoma

United States
European Organisation for Research and Treatment...

Completed

Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma

Glioblastoma

France, Germany, Netherlands, Switzerland, Greece, United States, Austria, Belgium, Italy
National Cancer Institute (NCI)

Completed

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Glioblastoma

United States
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Glioblastoma

Canada
Wake Forest University Health Sciences

Terminated

Bioenergetic Profiling and Cognition in GBM Patients

Glioblastoma

United States

Clinical Trials on Neoplasms, Neuroepithelial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations